T/CRHA 035-2024 Active Group standards

T/CRHA 035-2024 The technical specifications for evaluating peripheral neuropathy caused by chemotherapy

T/CRHA 035-2024 The technical specifications for evaluating peripheral neuropathy caused by chemotherapy

Publish Date: 2024-02-20 Implement Date: 2024-03-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Download

Basic Information

Standard Code: T/CRHA 035-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2024-02-20
Implement Date: 2024-03-01
Pages: 17 pages

Scope

Scope: This document stipulates the basic requirements for the assessment of peripheral neuropathy caused by chemotherapy, the assessment objects, the timing of assessment, the assessment content and methods, the determination of results, and the assessment process. This document is applicable to registered nurses in all levels and types of medical and health service institutions (comprehensive hospitals, community health service centers, etc.) who conduct assessments of peripheral neuropathy in patients receiving chemotherapy with neurotoxic drugs. Main technical content: The overall structure adopted in this document is as follows: 1. Scope; 2. Normative reference documents; 3. Terms and definitions; 4. Abbreviations; 5. Basic requirements; 6. Assessment objects; 7. Timing of assessment; 8. Assessment content and methods; 9. Determination of CIPN results; 10. Assessment process

Development Information

Pages: 17 pages

Related Standards

Contact Us